Papers/PMID:30043092
The effect of vitamin D3 supplementation on markers of cardiovascular health in hyperparathyroid, vitamin D insufficient women: a randomized placebo-controlled trial.
Endocrine2018The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
calciol — increases serum 25-hydroxyvitamin D concentration
Evidence strength: very limited.Findingreplicated ×33“Compared to placebo, vitamin D3 treatment significantly increased plasma levels of 25(OH)D and 1,25(OH)2D by 230% (95% CI: 189-272%) and 58% (190-271%), respectively.”
Quoted verbatim from The effect of vitamin D3 supplementation on markers of cardiovascular health in hyperparathyroid, vitamin D insufficient women: a randomized placebo-controlled trial.. - Study
- RCT
- Duration
- 3 months
- Dose
- vitamin D3 70 µg/day (2800 IU/day) for 12 weeks
- Population
- Healthy postmenopausal women with secondary hyperparathyroidism (PTH > 6.9 pmol/l) and 25(OH)D below 50 nmol/l, wintertime, double-blind
The effect of vitamin D3 supplementation on markers of cardiovascular health in hyperparathyroid, vitamin D insufficient women: a randomized placebo-controlled trial.2018PMID:3004309210.1007/s12020-018-1659-4Permalink